Acurx Pharmaceuticals, Inc. (ACXP)
Develops new antibiotics to fight dangerous drug-resistant bacterial infections.
$1.41-0.01%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-77.0%
The outlook
ACXP is trading near the bottom of its 52-week range, well below both its 50- and 200-day moving averages. Analyst sentiment leans bearish overall, though the average price target sits substantially above the current price. The stock shows minimal recent momentum.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range1% of the way from its 52-week low to high
Price targetAvg target +1106% vs current price
Analyst price target
~12-month · 3 analysts$17.00average target+1105.7% vs now
Now $1.41
Low $10.00High $31.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$6.1M
52-wk high
$8.44
52-wk low
$1.33
50-day avg
$1.65
200-day avg
$3.07
Trailing P/E
—